Effects of Anti-inflammatory Diet on Inflammatory Markers, Anxiety, Depression and Quality of Life in Patients With Inflammatory Bowel Disease
This clinical trial, sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, investigates the effects of an anti-inflammatory diet on patients with IBD. The study is currently recruiting participants and aims to validate a novel dietary intervention that could enhance patient quality of life and reduce inflammatory markers. If successful, this could position AID as a complementary treatment strategy in the management of IBD, potentially appealing to a growing market of patients seeking non-pharmacological interventions. The competitive landscape includes existing dietary management strategies, but the unique focus on a structured AID program and its integration with a digital application may provide a differentiated offering. Diligence considerations should include the scalability of the intervention and potential partnerships with digital health platforms.
Indication: Inflammatory Bowel Diseases
Modality: behavioral intervention
Target: Anti-inflammatory diet (AID) as a dietary intervention to modulate inflammatory markers and improve mental health outcomes in patients with Inflammatory Bowel Disease (IBD).
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Source URL: ClinicalTrials.gov
Source updated: Feb 17, 2025
Ingested: Jun 16, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Anti-inflammatory diet (AID) as a dietary intervention to modulate inflammatory markers and improve mental health outcomes in patients with Inflammatory Bowel Disease (IBD).
View original source fields
Condition raw: Inflammatory Bowel Diseases
Condition normalized: Inflammatory Bowel Diseases
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Anti-inflammatory diet (AID) as a dietary intervention to modulate inflammatory markers and improve mental health outcomes in patients with Inflammatory Bowel Disease (IBD).
Target normalized: Anti-inflammatory diet (AID) as a dietary intervention to modulate inflammatory markers and improve mental health outcomes in patients with Inflammatory Bowel Disease (IBD).